pooled estimates of diagnostic accuracy were computed using a random-effects model and Meta-DiSc Version 1.4. This meta-analysis is registered with PROSPERO (CRD42018074856).
Opiate Use for Headaches in Five Emergency Departments
LeFevere R, Salzman J, Moses L, Isenberger K/Healthpartners, St. Paul, MN Study Objectives: It is generally accepted that opiates should not be used for patients with primary headaches in the emergency department (ED), especially as firstline agents. Monitoring the use of opiates in such circumstances has become a common quality measure for physicians and EDs. Our primary objective was to describe opiate use for headaches in 5 different EDs, and also to examine whether there was significant variation between sites.
Methods: As part of a quality improvement project in 2017, each emergency physician in a 5-hospital system was asked to review 10 charts of 1 colleague. Patients who had a discharge diagnosis of headache over the previous year were grouped by treating physician and included in the analysis. Each physician's charts were then randomly assigned to a colleague who was instructed to review 10 charts. For each chart, the reviewing physician determined if an opiate was used to treat the patient's headache. If an opiate was given, it was noted whether it was the first medication given, or whether a nonopiate medication was given first. There were 5 hospitals included in the analysis. The majority of visits were at an urban adult and pediatric level-1 trauma center with an emergency medicine residency program. The other 4 sites were rural and suburban community hospitals with annual visit volumes between 8,000 and 14,000. The percentages of patients receiving opiates at the 5 sites were compared using a Fisher exact 3x2 contingency table.
Results: A total of 583 charts were reviewed by 52 physicians and included in the analysis (Table 1) . Opiates were used in 54/583 (9%) patients overall, and were the first medication given in 29/583 (5%) patients. There were small variations in the rate of opiate use between the sites, but none of the variation between any of the sites was statistically significant (p¼0.56).
Conclusions: Overall, use of opiates for headache in these 5 EDs was low, and there was no significant difference between the 5 sites. This could serve as a baseline rate of opiate use for headaches for future monitoring and studies. These results also suggest clinicians from varied ED settings are already minimizing opiate use for ED patients with headaches. Study Objectives: Many SCD patients do not have access to coordinated care and rely on emergency epartment (ED) visits to manage their pain. Inconsistent pain treatment leads to longer hospitalizations and patient distress. Patients with SCD often cite the care that is delivered in the ED as the area of health care in greatest need of improvement. In 2014, the National Heart, Lung, and Blood Institute released guidelines for the care of SCD, including recommendations for the management of acute sickle cell pain in the ED. The guidelines suggest that patients with SCD should be assessed and triaged rapidly, assigned high priority for evaluation by a physician, and receive their first analgesic within 60 minutes of arrival to the ED (or 30 min from Annals of Emergency Medicine S97 triage). The goal of this study is to determine factors associated with variability in the assessment and treatment of SCD patients presenting to the ED with acute pain. Methods: Design: We performed a cross-sectional analysis of SCD patients with pain crisis. Setting: ED of an urban, community university-affiliated teaching hospital. Participants: From 1/1/15 to 12/31/17, all SCD patients presenting to the adult ED with acute pain constant with vaso-occlusive crisis; excluding patients who presented for traumatic injuries or complaints where pain was not part of their reason for visit. Measures: Patient characteristic variables included age, sex, self-reported race, insurance, triage category, reason for visit, presenting pain score and disposition. Differences in pain management process outcomes included the following: 1) time in minutes from arrival to administration of first analgesic, and 2) triage to administration of first analgesic change in pain scores. Analgesic agents used and routes of administration were coded. Descriptive statistics are reported with standard deviations. We compare continuous data using 2-tailed Student's t-test; categorical data were analyzed with the chi-squared test.
Results: A total of 218 patients with 896 unique visits were recorded during our study period. The mean age of the population was 33 yrs, 76% female, 92% black, 81% non-Hispanic, and 68% had public insurance or were self-pay.
Using regression modeling, patients who met the NHLBI recommended time to first analgesia under 1 hr from time of arrival were 6.2 more likely (95% CI 3.9-9.7) to be determined to be ESI level 2. There were no other statistically significant differences in patient (demographics, reason for visit, presenting pain score) or treatment variables (type and route of administration of analgesic) identified. 119 of the 896 encounters were triaged as ESI level 2. This cohort was more likely to meet the goal of analgesia within 30 minutes of triage (OR 3.8, 95% CI 2.7-5.5). Patients identified as ESI level 2 were not more likely to be admitted (1.2, 95% CI 0.9-1.7).
Conclusions: Pain management of SCD patients remains a challenge. Our review reveals wide variability in the quality of care provided based on the NHLBI recommendations. We uncovered a significant opportunity for improvement related to the triage assessment. The association between ESI triage level and time to first analgesia suggests the importance of incorporating the ESI guidelines for triage of SCD patients. Study Objectives: Flank pain secondary to renal colic is a common presentation to emergency departments (ED). Pain control for this malady varies widely, including the use of NSAID and opioid medications, the latter of which evoke several potential side effects and ethical considerations given the current national opioid epidemic. Emergency physicians are among the leaders in health care in recognizing and confronting the opioid epidemic, from acknowledgement of the problem to advocating for naloxone, PDMPs, and medication-assisted treatment. The Alternatives to Opiates (ALTO) program of St. Joseph's University Medical Center, for example, aims to mitigate the unnecessary use of opioids by providing a range of existing and innovative protocols for pain management. The primary study objective is to compare the analgesic efficacy of IV lidocaine to IV ketorolac for patients with known or suspected renal colic evaluated in a suburban tertiary medical center ED. We present an interim safety analysis as the protocol is halfway completed and still blinded, with enrollment of 30 out of a proposed 60 patients.
Patient Characteristics & ED Approach to Pain
Methods: This is a prospective randomized double-blind cohort study. Patients are randomized by the inpatient pharmacy service to 2 groups: Group I receives acetaminophen 975 mg orally plus lidocaine 1.5 mg/kg via IV in 100 mL NS over 10 minutes while Group II receives acetaminophen 975 mg orally plus ketorolac 30 mg IV in 100 mL NS over 10 minutes. Primary study outcome is pain level using the 0-10 numeric rating scale measured at time 0 and at 5, 10, 15 and 30 minutes after medication administration. We set our goal sample size at 60 patients after determining a minimum of 50 patients with an alpha of 5% and difference of 6 units of change between treatments as the expected clinically significant change.
Results: With the blinded nature of the study protocol preserved, an interim safety analysis revealed that 7 of the 30 patients required rescue analgesia. None of the 30 patients experienced adverse effects from the medications administered.
Conclusions: An interim analysis revealed that 7 of 30 patients required rescue analgesia and none experienced any adverse effects from the medications received. Although a limited sample size, our study data suggests that IV lidocaine may be a reasonable alternative analgesic to opioids for the treatment of flank pain secondary to known or suspected renal colic, and with little increased risk of adverse medication effect.
NOTE: The views expressed are those of the author(s) and do not reflect the official policy of the Department of the Army, the Department of Defense or the U.S. Government.
Effectiveness and Safety of Droperidol in an Emergency Department in United States
Gaw CM, Cabrera D, Bellolio M, Mattson AE, Jeffery MM/Mayo Clinic, Rochester, MN Study Objectives: Droperidol is a dopamine D2 receptor antagonist, antipsychotic used extensively by emergency physicians, psychiatrists and anesthesiologists worldwide since 1967. It is an inexpensive, rapid-acting medication with a short half-life that functions as an analgesic, sedative, and antiemetic. It has been used for the treatment of headache, nausea, agitation, acute pain, chronic pain, pain in opiate-tolerance and multidrug-resistant abdominal pain. The United States Food and Drug Administration (FDA) issued a black box warning on the use of droperidol due to concerns of QT prolongation and potential fatal arrhythmias in 2001 after few case reports. Despite this, studies have found data supporting safe usage of low doses of droperidol, and its effectiveness in treating acute migraine headaches in the emergency department (ED) as well for sedation. The aim of this study was to evaluate the efficacy and safety of droperidol as an analgesic, antiemetic and sedative in a large cohort of patients presenting to the ED.
Methods: This was an observational cohort study of all droperidol administrations from 1/1/2012 through 4/19/2018 at an academic adult and pediatric ED with 77,000 annual ED visits located in United States. The primary endpoint was mortality within 24 hours of droperidol administration. Secondary endpoints included use of additional analgesia after the use of droperidol, called "rescue analgesia." We collected data on patient's date of visit, age, current medications, date and time of droperidol administration, any other medications administered in the same ED visit, chief complaint and final diagnosis. All patients who received droperidol were evaluated for the mortality and safety data. Among the patients who received droperidol for analgesia, we quantified those who required rescue analgesia 30 to 60 minutes after the
